Percutaneous Coronary Intervention

CHICAGO — In stable symptomatic patients with suspected CAD, a precision testing strategy was linked to a 70% reduction in death, MI or catheterization without obstructive CAD at 1 year compared with the usual testing, researchers reported.

Furosemide-induced high urine output with matched hydration vs. conventional IV hydration in PCI.

For adults who undergo PCI with a drug-eluting stent, recommendations for dual antiplatelet therapy have evolved from a standard 1-year duration for most patients to a more nuanced approach that balances risks for ischemia and bleeding.

Anticoagulation with low-molecular-weight heparin vs. no treatment for radial artery occlusion.

Outcomes after FFR-guided vs. angiography-guided strategy in treatment of non-infarction-related artery stenosis in acute MI with multivessel disease.

In a cohort of patients who underwent high-risk PCI, mechanical circulatory support with a microaxial blood pump was linked to lower odds of death, MI and cardiogenic shock compared with use of an intra-aortic balloon pump.

Abiomed announced the FDA has granted 510(k) clearance for its low-profile sheath for percutaneous placement of its mechanical circulatory support device used in high-risk patients undergoing PCI.

A hospital-wide quality improvement initiative including adoption of institutional guidelines, new prescribing prompts and a teaching curriculum was associated with a reduction in the use and duration of triple therapy after PCI, data show.

Increasing left main coronary artery plaque burden was associated with long-term all-cause and cardiac mortality in patients who did not have revascularization, even if the lumen area was preserved, researchers reported.

In adults who undergo PCI, concomitant extracardiac vascular disease is associated with worse clinical outcomes, including all-cause death, regardless of the organ involved and the number of vascular beds, researchers reported.